Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
2021; Centers for Disease Control and Prevention; Volume: 70; Issue: 11 Linguagem: Inglês
10.15585/mmwr.mm7011e3
ISSN1545-861X
AutoresAmadea Britton, Kara M. Jacobs Slifka, Chris Edens, Srinivas Nanduri, Stephen M. Bart, Nong Shang, Adora Harizaj, Jillian N. Armstrong, Kerui Xu, Hanna Y. Ehrlich, Elizabeth Soda, Gordana Derado, Jennifer R. Verani, Stephanie J. Schrag, John A. Jernigan, Vivian Leung, Sunil Parikh,
Tópico(s)COVID-19 epidemiological studies
ResumoThis report describes an analysis of two Connecticut skilled nursing facilities that found partial vaccination, >14 days after the first dose through 7 days after the second dose, with the Pfizer-BioNTech COVID-19 vaccine 63% effective against SARS-CoV-2 infection.
Referência(s)